M
IMEPro
F32.1 Psychiatric
Updated March 2026

Major depressive disorder, single episode, moderate

ICD-10 Code: F32.1 · Body Part: Head/Brain (TBI)

QME Evaluation Process

Psychiatric interview, PHQ-9, functional assessment, occupational impact evaluation. Chapter 14 impairment rating. Common reactive depression following industrial injury.

Typical Impairment Rating

15-30% WPI

AMA Guides Edition

5th Edition

Common Treatments

+ CBT
+ SSRI/SNRI medication
+ Psychotherapy

Related Conditions

Body Part Guide

Head/Brain (TBI) Evaluation Guide

Impairment rating methods, common conditions, and QME evaluation protocols

View Guide →

QME Specialties for Major depressive disorder, single episode, moderate

Find a QME Specialist

Browse QME-certified physicians who evaluate major depressive disorder, single episode, moderate and related head/brain (tbi) conditions in California.

Browse Neurology Physicians →

Frequently Asked Questions

What is Major depressive disorder, single episode, moderate (F32.1)?

Major depressive disorder, single episode, moderate is an ICD-10 diagnosis code (F32.1) classified under Psychiatric conditions. It affects the Head/Brain (TBI) and is commonly encountered in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.

How is F32.1 rated for impairment?

The typical whole person impairment (WPI) range for Major depressive disorder, single episode, moderate is 15-30% WPI. The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.

What is the QME evaluation process for F32.1?

Psychiatric interview, PHQ-9, functional assessment, occupational impact evaluation. Chapter 14 impairment rating. Common reactive depression following industrial injury.

What treatments are common for Major depressive disorder, single episode, moderate?

Common treatments for Major depressive disorder, single episode, moderate include CBT, SSRI/SNRI medication, Psychotherapy. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.